Highlights and Quick Summary
- Selling, General and Administrative Expense of Revenue for the quarter ending September 30, 2023 was 1277.55% (a 357.12% increase compared to previous quarter)
- Year-over-year quarterly Selling, General and Administrative Expense of Revenue increased by 156.7%
- Annual Selling, General and Administrative Expense of Revenue for 2022 was 705.62% (a 21.03% increase from previous year)
- Annual Selling, General and Administrative Expense of Revenue for 2021 was 583.02% (a 406.53% increase from previous year)
- Annual Selling, General and Administrative Expense of Revenue for 2020 was 115.1% (a -32.7% decrease from previous year)
- Twelve month Selling, General and Administrative Expense of Revenue ending September 30, 2023 was 522.66% (a 17.27% increase compared to previous quarter)
- Twelve month trailing Selling, General and Administrative Expense of Revenue decreased by -25.93% year-over-year
Trailing Selling, General and Administrative Expense of Revenue for the last four month:
| 30 Sep '23 | 30 Jun '23 | 31 Mar '23 | 31 Dec '22 |
|---|---|---|---|
| 522.66% | 445.68% | 633.47% | 705.62% |
Visit stockrow.com/ABSI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Selling, General and Administrative Expense of Revenue of Absci Corporation
Most recent Selling, General and Administrative Expense of Revenueof ABSI including historical data for past 10 years.Interactive Chart of Selling, General and Administrative Expense of Revenue of Absci Corporation
Absci Corporation Selling, General and Administrative Expense of Revenue for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 1277.55% | 279.48% | 755.95% | – | – |
| 2022 | 497.69% | 481.51% | 1048.6% | 1329.55% | 705.62% |
| 2021 | 632.44% | 632.42% | 711.4% | 440.73% | 583.02% |
| 2020 | 88.45% | 137.23% | 152.66% | 169.76% | 115.1% |
| 2019 | – | – | – | – | 171.02% |
Business Profile of Absci Corporation
Sector: Healthcare
Industry: Biotechnology